Advertisement

Viral, Fungal and Atypical Bacterial Infections in Cystic Fibrosis

  • Barbara Przyklenk
  • Adolf Bauernfeind
Chapter
  • 48 Downloads
Part of the Respiratory Pharmacology and Pharmacotherapy book series (RPP)

Summary

The role of respiratory viral and fungal agents in cystic fibrosis (CF) was investigated. Among the serologically proven viral infections, adenovirus was the most frequent (53%), followed by parainfluenza (24%) and RSV (20%); 54% of the episodes lead to hospital admission. A significant change in microbial flora of respiratory secretions was seen in 88% of the episodes, mainly with P. aeruginosa, and 65% of cases with initial colonization with P. aeruginosa are associated with a viral respiratory tract infection. It is hypothesised that viral respiratory infections to a predamaged lung in CF predispose to colonization with P. aeruginosa. Many of the CF-patients show elevated serum IgG to C. albicans, and therefore, C. albicans should not be considered a harmless colonizing mold. The prevalence of A. fumigatus increases with age. Of the CF-patients with A. fumigatus, 73% showed elevated specific serum IgG to this fungus. No correlation was found between culture, specified IgG to A. fumigatus and either specific Aspergillus IgE or total serum IgE. Maintaining good pulmonary condition and reduction of exposure to A. fumigatus may prevent colonization and infection with this mold.

Keywords

Cystic Fibrosis Respiratory Syncytial Virus Invasive Aspergillosis Microbial Flora Initial Colonization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Wright PF, Khaw KT, Oxman MN, Shwachman H. Evaluation of the safety of amantadine HCl and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis 1976; 134: 144–149.PubMedCrossRefGoogle Scholar
  2. 2.
    Roggendorf M, Wigand R, Deinhardt F, Frösner G. Enzyme-linked immunosorbent assay for acute adenovirus infection. J Virol Methods 1982; 4: 27 35.Google Scholar
  3. 3.
    Przyklenk B, Bauernfeind A, Bertele RM, Deinhardt D, Harms K. Viral infections of the respiratory tract in patients with cystic fibrosis. Serodiagn Immunother Infect Dis 1988; 2: 217 225.Google Scholar
  4. 4.
    Enders G, Virusinfektionen. In: Thomas L, editor. Labor and Diagnose. 3rd edition. Marburg: Medizinische Verlagsgesellschaft, 1988: 1285–1330.Google Scholar
  5. 5.
    Bauernfeind A, Bertele RM, Harms K, Hörl G, Jungwirth R, Petermüller C, Przyklenk B, Weisslein-Pfister C. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987; 15: 270 277.Google Scholar
  6. 6.
    Przyklenk B, Bauernfeind A, Hörl G, Emminger G. Serologic response to Candida albicans and Aspergillus fùmigatus in cystic fibrosis. Infection 1987; 15: 308–310.PubMedCrossRefGoogle Scholar
  7. 7.
    Wang EEL, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 1984; 311: 1653 1658.Google Scholar
  8. 8.
    Pribble CG, Black PG, Bosso JA, Turner RB. Clinical manifestations of exacerbations of cystic fibrosis associated with non-bacterial infections. J Pediatr 1990; 117: 200–204.PubMedCrossRefGoogle Scholar
  9. 9.
    Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 1989; 143: 662–668.PubMedGoogle Scholar
  10. 10.
    Stroobant J. Viral infections in cystic fibrosis. J R Soc Med 1986; 79 (12): 19–22.PubMedGoogle Scholar
  11. 11.
    Johansen HK, Hoiby N. Seasonal onset of initial and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992; 47: 109–111.PubMedCrossRefGoogle Scholar
  12. 12.
    Forsyth KD, Hohmann AW, Martin AJ, Bradley J. IgG antibodies to Aspergillus fùmigatus in cystic fibrosis: a laboratory correlate of disease activity. Arch Dis Child 1988; 63: 953–957.PubMedCrossRefGoogle Scholar
  13. 13.
    Haase G, Skopnik H, Groten T, Kusenbach G, Posselt H-G. Long-term cultures from sputum of patients with cystic fibrosis. Mycoses 1991; 34: 373–376.PubMedCrossRefGoogle Scholar
  14. 14.
    Thomassen J, Klinger JD, Badger SJ, van Heckeren DW. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr 1984; 104: 352–356.PubMedCrossRefGoogle Scholar
  15. 15.
    Whittier S, Hopfer RL, Knowles MR, Gilligan PH. Improved recovery of mycobacteria from respiratroy secretions of patients with cystic fibrosis. J Clin Microbiol 1993; 31: 861–864.PubMedGoogle Scholar
  16. 16.
    Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991; 4: 35–51.PubMedGoogle Scholar
  17. 17.
    Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE, Edwards LJ, Knowles MR. Nontuberculous myobacteria in adult patients with cystic fibrosis. Chest 1992; 102: 70 75.Google Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 1996

Authors and Affiliations

  • Barbara Przyklenk
    • 1
  • Adolf Bauernfeind
    • 2
  1. 1.University Children’s HospitalLudwig-Maximilians-UniversitätMünchenGermany
  2. 2.Max von Pettenkofer-InstitutLudwig-Maximilians-UniversitätMunchenGermany

Personalised recommendations